Kyung-Hee Lee

Title: Innovations of Kyung-Hee Lee in Cardioprotective Pharmaceutical Compositions

Introduction

Kyung-Hee Lee is a notable inventor based in Sungnam-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that offer cardioprotective effects. His work focuses on innovative solutions for treating ischemic heart diseases and cerebrovascular conditions.

Latest Patents

Kyung-Hee Lee holds a patent for "Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same." This invention relates to benzothiophen-2-carbonylguanidine derivatives that exhibit a potent inhibitory effect on the sodium/hydrogen exchanger NHE-I. The derivatives have been shown to improve functional recovery from ischemia/reperfusion-induced heart injury in isolated ischemic heart models. They also significantly reduce myocardial infarct size in in vivo ischemic animal models, demonstrating excellent cardioprotective effects.

Career Highlights

Kyung-Hee Lee is affiliated with the Korea Research Institute of Chemical Technology, where he continues to advance his research in pharmaceutical compositions. His innovative work has the potential to transform treatment protocols for patients suffering from ischemic heart diseases, such as myocardial infarction, arrhythmia, and angina pectoris. Additionally, his derivatives are beneficial for cerebrovascular diseases, including cerebral stroke.

Collaborations

Kyung-Hee Lee collaborates with esteemed colleagues, including Kyu Yang Yi and SunKyung Lee, who contribute to the research and development of his innovative pharmaceutical compositions.

Conclusion

Kyung-Hee Lee's contributions to the field of cardioprotective agents highlight the importance of innovation in pharmaceutical research. His work not only addresses critical health issues but also paves the way for future advancements in treatment methodologies.